Skip to main content
HeartCited

Chitosan 用于 高胆固醇血症(高脂血症)

C 证据 来自小型研究的证据有限,但存在一些积极信号。

Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dchitosan\u0026condition\u003Dhigh\u002Dcholesterol'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

Cochrane review of 14 RCTs: modest total cholesterol reduction (6-14 mg/dL). Clinical significance is debated. Fat-binding mechanism has theoretical appeal but limited practical impact.

Key Study Findings

Other
Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical …
Dose: None vs: None Outcome: Cognitive function 效果: None None

研究人群: Rat model

Other
Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity.
Dose: None vs: None Outcome: Oxidative stress, neuroinflammation, apoptosis 效果: None None

研究人群: AlCl3-induced neurotoxicity rat model

Key Statistics

14

研究数量

1100

受试者

Positive

C

等级

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

fatbinding:
1,500-3,000 mg/day before meals
cholesterolsupport:
1,000-3,000 mg/day

上限: Not formally established; GI side effects at higher doses

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive --
None -- Positive --

最佳服用时间: 15-30 minutes before meals containing dietary fat

Safety & Side Effects

已报告的副作用

  • Constipation
  • Gas and bloating
  • Nausea
  • Allergic reactions in those with shellfish allergy (contraindicated)

已知相互作用

  • Fat-soluble vitamins (A, D, E, K — may reduce absorption)
  • Oral medications (may bind and reduce absorption — separate by 2 hours)
  • Warfarin (may reduce vitamin K absorption, affecting INR)

可耐受最高摄入量: Not formally established; GI side effects at higher doses

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Chitosan help with 高胆固醇血症(高脂血症)?
Based on 14 studies with 1,100 participants, there is limited but promising evidence that Chitosan may support 高胆固醇血症(高脂血症) management. Our evidence grade is C (Some Evidence).
How much Chitosan should I take for 高胆固醇血症(高脂血症)?
Studies have used various dosages. A commonly studied range is 1,500-3,000 mg/day before meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chitosan?
Reported side effects may include Constipation, Gas and bloating, Nausea, Allergic reactions in those with shellfish allergy (contraindicated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chitosan and 高胆固醇血症(高脂血症)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 14 peer-reviewed studies with 1,100 total participants. The overall direction of effect is positive.

References

  1. [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
  2. [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
  3. [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。